Unknown

Dataset Information

GW8510 increases insulin expression in pancreatic alpha cells through activation of p53 transcriptional activity.


ABSTRACT:

Background

Expression of insulin in terminally differentiated non-beta cell types in the pancreas could be important to treating type-1 diabetes. Previous findings led us to hypothesize involvement of kinase inhibition in induction of insulin expression in pancreatic alpha cells.

Methodology/principal findings

Alpha (αTC1.6) cells and human islets were treated with GW8510 and other small-molecule inhibitors for up to 5 days. Alpha cells were assessed for gene- and protein-expression levels, cell-cycle status, promoter occupancy status by chromatin immunoprecipitation (ChIP), and p53-dependent transcriptional activity. GW8510, a putative CDK2 inhibitor, up-regulated insulin expression in mouse alpha cells and enhanced insulin secretion in dissociated human islets. Gene-expres

SUBMITTER: Fomina-Yadlin D 

PROVIDER: S-EPMC3252286 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature